Tel: +44(0)20 7691 0984 Email: Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...


All the latest conference updates; those that we are attending and the studies that we are presenting

Each year ASENT Annual meeting features sessions on emerging therapies in a wide variety of neurologic disease states from Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy, and a variety of other neurodegenerative Disorders.

Transpharmation will be presenting posters on the topics of “Modulation of the p38 MAPK Pathway in Peripheral Blood Mononuclear Cells (PBMCs): Implications for screening novel anti-inflammatories in Alzheimer’s Disease (AD)” & “Establishment of a reversal learning assay in rats to investigate the effects of novel compounds on executive function.” To get more info on the topics of discussion and registration process please go to


Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120



Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design